Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2026)
Regeneron Pharmaceuticals (REGN) recorded quarterly Exchange Rate Effect of -$900000.0 in Q1 2026, down 200.0% quarter-over-quarter from -$300000.0 in Q4 2025, and down 250.0% on a YoY basis from $600000.0 in Q1 2025.
Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$900000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 250.0% year-over-year to -$900000.0; the TTM figure through Mar 2026 stood at -$1.2 million (down 400.0% YoY), while the FY2025 annual figure was $300000.0, up 142.86% from the prior year.
- Exchange Rate Effect was -$900000.0 for Q1 2026 at Regeneron Pharmaceuticals, down from -$300000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $800000.0 in Q3 2024 to a low of -$900000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged -$141666.7 across 4 years, with a median of -$300000.0 in 2024.
- Biggest YoY gain for Exchange Rate Effect was 500.0% in 2024; the steepest drop was 450.0% in 2024.
- A 4-year view of Exchange Rate Effect shows it stood at $200000.0 in 2023, then tumbled by 450.0% to -$700000.0 in 2024, then surged by 57.14% to -$300000.0 in 2025, then tumbled by 200.0% to -$900000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$900000.0 (Q1 2026), -$300000.0 (Q4 2025), and -$400000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -900,000.00 |
| Mar 31, 2026 | -900,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | -300,000.00 |
| Jun 30, 2024 | -300,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |